Two pill versions of the medications, Foundayo and Wegovy, are now approved by FDA for obesity and weight loss, along with injectables like Zepbound
Metformin has been found to produce antidepressive effects by enhancing the responsiveness of the serotoninergic neurons in the dorsal raphe [47], but the main impact of GLP-1 is exerted by AMP-activated protein kinase (AMPK), a major cellular regulator of lipid and glucose metabolism [48]
When combined with physician-led nutritional frameworks and metabolic tracking, Semaglutide optimizes cellular fat metabolism
Abstract This large community-based cohort study investigates the impact of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), specifically Liraglutide and Semaglutide, on the risk of developing psychiatric conditions such as depression, anxiety, and suicidal behaviors in patients with obesity